Clinical trial
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV: The ANRS CO3 Aquitaine Cohort - AquiVIH-NA
NCT03296202 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV: The ANRS CO3 Aquitaine Cohort - AquiVIH-NA
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 18, 2017
- Completion date
- December 31, 2026
- Enrollment
- 7,500 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
antiretroviral agents, hiv infections